Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Glial activation and inflammation coincide with neurofibrillary tangle (NFT) formation in neurons. However, the mechanism behind the interaction between tau fibrils and glia is poorly understood. Here, we found that tau preformed fibrils (PFFs) caused induction of inflammation in microglia by specifically activating the TLR2/MyD88, but not the TLR4/MyD88, pathway. Accordingly, the WT TLR2-interacting domain of MyD88 (wtTIDM) peptide inhibited tau PFF-induced activation of the TLR2/MyD88/NF-κB pathway, resulting in reduced inflammation. Nasal administration of wtTIDM in P301S tau-expressing PS19 mice was found to inhibit gliosis and inflammatory markers, as well as to reduce pathogenic tau in the hippocampus, resulting in improved cognitive behavior in PS19 mice. The inhibitory effect of wtTIDM on tau pathology was absent in PS19 mice lacking TLR2, reinforcing the essential involvement of TLR2 in wtTIDM-mediated effects in vivo. Studying the mechanism further, we found that the tau promoter harbored a potential NF-κB-binding site and that proinflammatory molecules increased transcription of tau in neurons via NF-κB. These results suggest that tau-induced neuroinflammation and neuropathology require TLR2 and that neuroinflammation directly upregulates tau in neurons via NF-κB, highlighting a direct connection between inflammation and tauopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Brain-derived tau proteins may activate the inflammatory response in microglia via the TLR2/MyD88/NF-κB pathway.251”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [251]
The cited source says what the claim attributes to it.
In the citing paper
“According to recent studies, pro-inflammatory cytokines like IL-1β may induce an increase in tau transcription in human primary neurons by activating the NF-κB signaling pathway in neurons.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 2×
“Therefore, blocking TLR2/MyD88/ NF-κB–mediated inflammation with the synthetic peptide wtTIDM holds potential therapeutic value against AD, PSP, FTD, CBD, and other tauopathies.”
BackgroundTau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“(9), depletion of microglia halts tau propagation.”
PSD-95 Involvement in Maturation of Excitatory Synapses
El-Husseini, A. E.-D., Schnell, E., Chetkovich, D. M., Nicoll, R. A., & Bredt, D. S. (2000) · Science · doi:10.1126/science.290.5495.1364 · Cited by 1,303 · cited 1×
“PSD95 is greatly implicated in scaffolding of multiple receptor proteins activated by the excitatory neurotransmitter glutamate and in promoting glutamate receptor–mediated Ca influx required for memory formation (48, 49).”
BackgroundBlock of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123
von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806 · cited 1×
“Mutated tau has a higher tendency to self-aggregate and form paired helical filaments, which is dependent on its R2 and R3 regions at the C-terminus (29) and might also be dependent on heavy phosphorylation of certain residues (30, 31).”
BackgroundNeurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715 · cited 2×
“Therefore, blocking TLR2/MyD88/ NF-κB–mediated inflammation with the synthetic peptide wtTIDM holds potential therapeutic value against AD, PSP, FTD, CBD, and other tauopathies.”
BackgroundIba, M., Guo, J. L., McBride, J. D., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2642-12.2013 · Cited by 664 · cited 1×
“Injection of tau PFFs in entorhinal cortex not only recapitulates the signature mode of its propagation toward hippocampus, but also forms more complex proteinase-resistant aggregates that are immunostained by TG3, a conformation-specific phospho-tau mAb, by anti-acetylated tau K280 antibody and also strongly stained…”
BackgroundCD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · cited 2×
“There was a possibility that PFF-induced NF-κB activation might also result from activation of other TLRs, specifically TLR4, which is known to interact with different oligomeric aggregated forms of proteins including Aβ (43, 44).”
BackgroundResultDejanovic, B., Huntley, M. A., De Mazière, A., Meilandt, W. J., Wu, T., Srinivasan, K., Jiang, Z., Gandham, V., Friedman, B. A., Ngu, H., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.014 · Cited by 517 · cited 1×
“Loss of synaptic function and reduction in synaptic proteins are some important pathological features found in tauopathy brains even prior to neuronal demise (24, 25).”
BackgroundReactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer’s Disease
Serrano-Pozo, A., Mielke, M. L., Gómez-Isla, T., Betensky, R. A., Growdon, J. H., Frosch, M. P., & Hyman, B. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.047 · Cited by 488
Kaufman, S. K., Sanders, D. W., Thomas, T. L., Ruchinskas, A. J., Vaquer-Alicea, J., Sharma, A. M., Miller, T. M., & Diamond, M. I. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.055 · Cited by 450
Near-atomic model of microtubule-tau interactions
Kellogg, E. H., Hejab, N. M. A., Poepsel, S., Downing, K. H., DiMaio, F., & Nogales, E. (2018) · Science · doi:10.1126/science.aat1780 · Cited by 416
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy
Wang, C., Fan, L., Khawaja, R. R., Liu, B., Zhan, L., Kodama, L., Chin, M., Li, Y., Le, D., Zhou, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29552-6 · Cited by 333
Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease
Jana, M., Palencia, C. A., & Pahan, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7254 · Cited by 330
Self-citationThe role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease
Hopp, S. C., Lin, Y., Oakley, D., Roe, A. D., DeVos, S. L., Hanlon, D., & Hyman, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1309-z · Cited by 286
Absence of CX3CR1 impairs the internalization of Tau by microglia
Bolós, M., Llorens-Martín, M., Perea, J. R., Jurado-Arjona, J., Rábano, A., Hernández, F., & Avila, J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0200-1 · Cited by 231
Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Javonillo, D. I., Tran, K. M., Phan, J., Hingco, E., Kramár, E. A., da Cunha, C., Forner, S., Kawauchi, S., Milinkeviciute, G., Gomez-Arboledas, A., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.785276 · Cited by 203
Intersection of pathological tau and microglia at the synapse
Vogels, T., Murgoci, A.-N., & Hromádka, T. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0754-y · Cited by 197 · cited 2×
“In the last decade, numerous studies have demonstrated antiinflammatory and neuroprotective effects of different pharmacological molecules in tauopathy brains (23), but in the absence of proper knowledge about tau-induced receptor activation in glial cells, these approaches might face several challenges.”
BackgroundBrelstaff, J., Tolkovsky, A. M., Ghetti, B., Goedert, M., & Spillantini, M. G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.072 · Cited by 195
Dutta, D., Jana, M., Majumder, M., Mondal, S., Roy, A., & Pahan, K. (2021) · Nature Communications · doi:10.1038/s41467-021-25767-1 · Cited by 195
Self-citationTransmission of tauopathy strains is independent of their isoform composition
He, Z., McBride, J. D., Xu, H., Changolkar, L., Kim, S.-J., Zhang, B., Narasimhan, S., Gibbons, G. S., Guo, J. L., Kozak, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13787-x · Cited by 176
Roy, A., Jana, M., Corbett, G. T., Ramaswamy, S., Kordower, J. H., Gonzalez, F. J., & Pahan, K. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.028 · Cited by 167
Self-citationTau Oligomers and Fibrils Induce Activation of Microglial Cells
Morales, I., Jiménez, J. M., Mancilla, M., & Maccioni, R. B. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-131843 · Cited by 160
DIPATRE, P. L., & GELMAN, B. B. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00004 · Cited by 157
Roy, A., Jana, A., Yatish, K., Freidt, M. B., Fung, Y. K., Martinson, J., & Pahan, K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.026 · Cited by 154
Self-citationInduction of Nitric-oxide Synthase and Activation of NF-κB by Interleukin-12 p40 in Microglial Cells
Pahan, K., Sheikh, F. G., Liu, X., Hilger, S., McKinney, M., & Petro, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008262200 · Cited by 153
Self-citationStancu, I.-C., Vasconcelos, B., Ris, L., Wang, P., Villers, A., Peeraer, E., Buist, A., Terwel, D., Baatsen, P., Oyelami, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1413-4 · Cited by 143
Rangasamy, S. B., Jana, M., Roy, A., Corbett, G. T., Kundu, M., Chandra, S., Mondal, S., Dasarathi, S., Mufson, E. J., Mishra, R. K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96209 · Cited by 139 · cited 19×
“Similarly, the WT TLR2–interacting domain of MyD88 (wtTIDM) peptide, capable of blocking the interaction of TLR2 with MyD88 (16), prevented tau-mediated TLR2 activation in microglia.”
BackgroundMethodInfluentialSelf-citationCognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
Huber, C. M., Yee, C., May, T., Dhanala, A., & Mitchell, C. S. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170490 · Cited by 131
Ghosh, A., Jana, M., Modi, K., Gonzalez, F. J., Sims, K. B., Berry-Kravis, E., & Pahan, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610659 · Cited by 130
Self-citationJana, A., Modi, K. K., Roy, A., Anderson, J. A., van Breemen, R. B., & Pahan, K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9447-7 · Cited by 129
Self-citationJana, A., & Pahan, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1243-10.2010 · Cited by 129
Self-citationSun, Y., Guo, Y., Feng, X., Jia, M., Ai, N., Dong, Y., Zheng, Y., Fu, L., Yu, B., Zhang, H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01749-w · Cited by 122 · cited 1×
“Along with microglia, activation and resulting inflammation of astrocytes are also reported in tauopathy brains (20, 21).”
BackgroundModi, K. K., Roy, A., Brahmachari, S., Rangasamy, S. B., & Pahan, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130398 · Cited by 113
Self-citationTumor necrosis factor‐α at the crossroads of neuronal life and death during HIV‐associated dementia
Saha, R. N., & Pahan, K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01942.x · Cited by 111
Self-citationKhasnavis, S., & Pahan, K. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9552-2 · Cited by 111
Self-citationPahan, K., Jana, M., Liu, X., Taylor, B. S., Wood, C. A., & Fischer, S. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200250200 · Cited by 110
Self-citationAspirin binds to PPARα to stimulate hippocampal plasticity and protect memory
Patel, D., Roy, A., Kundu, M., Jana, M., Luan, C.-H., Gonzalez, F. J., & Pahan, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802021115 · Cited by 93
Self-citationMicroglia display modest phagocytic capacity for extracellular tau oligomers
Majerova, P., Zilkova, M., Kazmerova, Z., Kovac, A., Paholikova, K., Kovacech, B., Zilka, N., & Novak, M. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0161-z · Cited by 90 · cited 1×
“However, the efficiency of microglia in degrading tau oligomers or fibrils is still questionable, as addition of AD-derived tau has been shown to generate dystrophic microglia with swelling of lysosomes (12, 36).”
BackgroundPahan, K., Liu, X., McKinney, M. J., Wood, C., Sheikh, F. G., & Raymond, J. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742288.x · Cited by 87
Self-citationJana, M., Jana, A., Liu, X., Ghosh, S., & Pahan, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4142 · Cited by 85
Self-citationJana, M., Jana, A., Pal, U., & Pahan, K. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9340-y · Cited by 83
Self-citationvan Olst, L., Verhaege, D., Franssen, M., Kamermans, A., Roucourt, B., Carmans, S., Ytebrouck, E., van der Pol, S. M. A., Wever, D., Popovic, M., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.003 · Cited by 75
Astrocyte senescence and SASP in neurodegeneration: tau joins the loop
Ungerleider, K., Beck, J., Lissa, D., Turnquist, C., Horikawa, I., Harris, B. T., & Harris, C. C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1909260 · Cited by 71
Tang, S. J., Fesharaki-Zadeh, A., Takahashi, H., Nies, S. H., Smith, L. M., Luo, A., Chyung, A., Chiasseu, M., & Strittmatter, S. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00976-9 · Cited by 70
Upregulation of BDNF and hippocampal functions by a hippocampal ligand of PPARα
Patel, D. R., Roy, A., Raha, S., Kundu, M., Gonzalez, F. J., & Pahan, K. (2020) · JCI Insight · doi:10.1172/jci.insight.136654 · Cited by 60
Self-citationDutta, D., Kundu, M., Mondal, S., Roy, A., Ruehl, S., Hall, D. A., & Pahan, K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104575 · Cited by 58
Self-citationIn vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics
Xu, H. W., O’Reilly, M., Gibbons, G. S., Changolkar, L. N., McBride, J. D., Riddle, D. M., Zhang, B., Stieber, A., Nirschl, J., Kim, S., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02253-4 · Cited by 55
Perea, J. R., Ávila, J., & Bolós, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.007 · Cited by 54 · cited 1×
“However, monomeric tau-induced inflammation was not found to be as enormous as fibrillar tau as the extent of upregulation of inflammatory molecules was much less, whereas the dose required to induce inflammation was much higher compared with the PFFs used by us and also by another study (40, 41).”
ResultRangasamy, S. B., Corbett, G. T., Roy, A., Modi, K. K., Bennett, D. A., Mufson, E. J., Ghosh, S., & Pahan, K. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150040 · Cited by 53
Self-citationToll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38
Vasselon, T., Hanlon, W. A., Wright, S. D., & Detmers, P. A. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.503 · Cited by 51
Odawara, T., Iseki, E., Kosaka, K., Akiyama, H., Ikeda, K., & Yamamoto, T. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11595-n · Cited by 47 · cited 1×
“Ongoing research clearly demonstrates that microglia phagocytose extracellular tau (32) via interaction with CX3CR1 (33), and therefore, tau aggregates are also found to be localized in microglia in AD animals as well as in patients’ brains (34, 35).”
BackgroundPaidi, R. K., Jana, M., Mishra, R. K., Dutta, D., Raha, S., & Pahan, K. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09979-8 · Cited by 46
Self-citationUpregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid
Chakrabarti, S., Jana, M., Roy, A., & Pahan, K. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666180507104755 · Cited by 43
Self-citationGottschalk, C. G., Jana, M., Roy, A., Patel, D. R., & Pahan, K. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.3018-19.2021 · Cited by 43
Self-citationMolecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study
Holland, N., Malpetti, M., Rittman, T., Mak, E. E., Passamonti, L., Kaalund, S. S., Hezemans, F. H., Jones, P. S., Savulich, G., Hong, Y. T., et al. (2022) · Brain · doi:10.1093/brain/awab282 · Cited by 39
Shinohara, Y. (2012) · Hippocampus · doi:10.1002/hipo.20950 · Cited by 33
Eckenweber, F., Medina-Luque, J., Blume, T., Sacher, C., Biechele, G., Wind, K., Deussing, M., Briel, N., Lindner, S., Boening, G., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01883-5 · Cited by 32
Paidi, R. K., Jana, M., Mishra, R. K., Dutta, D., & Pahan, K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100144 · Cited by 31
Self-citationChen, R., Wang, Z., Zhi, Z., Tian, J., Zhao, Y., & Sun, J. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.07.019 · Cited by 30
Dutta, D., Majumder, M., Paidi, R. K., & Pahan, K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105318 · Cited by 24
Self-citationTransmission of Tau Pathology Induced by Synthetic Preformed Tau Filaments
Reyes, J. F., Rey, N. L., & Angot, É. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0725-13.2013 · Cited by 12
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“251 Research by Ising et al. suggests that tau proteins can activate the NLRP3 in fl ammasome, which then promotes excessive tau phosphorylation and aggregation by affecting speci fi c tau kinases and phosphatases.”
BackgroundCyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
The impact of physical exercise on neuroinflammation mechanism in Alzheimer’s disease
Hu, J., Huang, B., & Chen, K. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1444716 · Cited by 59
The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis
Burke, M. R., Sotiropoulos, I., & Waites, C. L. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.08.015 · Cited by 46
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Li, W., & Li, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00407-y · Cited by 38
Metadata
- Authors
- Dutta, D., Jana, M., Paidi, R. K., Majumder, M., Raha, S., Dasarathy, S., & Pahan, K.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Pahan, Kalipada
- Venue
- Journal of Clinical Investigation
- Published
- 2023-09-15
- Volume
- 133
- Issue
- 18
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10503811
- OpenAlex
- W4385667068
- Cited by
- 87
- References
- 68
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 21 · 2023: 3
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (AG069229, 1IK6 BX004982, IK6 BX004982, AG050431)
- University of Pennsylvania
- National Institutes of Health (1IK6 BX004982, AG069229, AG050431)
- National Institute on Aging (R21AG069229, R01AG050431)
- National Center for Complementary and Integrative Health (R01AT010980)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- tau fibrils, neuroinflammation, TLR2, MyD88, NF-κB signaling, microglial activation, glial activation, tauopathy, Alzheimer's disease, NF-kappaB binding site, gliosis, P301S tau, PS19 mice, cognitive behavior, hippocampus
- MeSH terms
- Neuroinflammatory Diseases, Alzheimer Disease, Animals, Disease Models, Animal, Inflammation, Mice, Transgenic, NF-kappa B, tau Proteins, Microglia, Adaptor Proteins, Signal Transducing, Toll-Like Receptor 2, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.